Save the Date: Dueling Endocrinologists Discussing Hypothyroidism Diagnosis and treatment: Commonalities and Differences

Posted on September 10, 2025 by MaryO

 

  • Dr. Friedman will be joined by Brittany Henderson, MD, ECNU for an exciting GoodHormoneHeath Webinar on Dueling Academic-Based Endocrinologists discussing state-of-the-art hypothyroidism diagnosis and treatment: Commonalities and Differences

    Each expert will discuss the following topics:

  • How is mild hypothyroidism diagnosed?
  • Why are full thyroid panels and not just TSH needed?
  • What is the role of rT3?
  • How to optimally use all types of thyroid hormone including NDT
  • Why both conventional and alternative providers have it wrong?
  • They will briefly discuss the proposed ban on desiccated thyroid by the FDA.

Sunday • September 14• 5 PM PDT/ 8 PM EDT
Via Zoom Click here to join the meeting or
https://us06web.zoom.us/j/4209687343?omn=87459672811
OR
16694449171,,4209687343#
Slides and copy of the paper and the press release will be available before the webinar and recording after the meeting at slides
OR
Join on Facebook Live – https://www.facebook.com/goodhormonehealth at 5 PMPDT/ 8 PM EDT

Your phone/computer will be muted on entry. There will be plenty of time for questions using the chat button.

Filed under: Meetings and Conferences, Webinar | Tagged: , , , | Leave a comment »

Webinar: Endoscopic Endonasal Surgery for the Treatment of Cushing’s Disease

Posted on June 6, 2016 by MaryO

Mon, Jun 13, 2016 11:00 AM – 12:00 PM EDT

Show in My Time Zone
Presented by:
Dr. Maria Koutourousiou
Webinar DescriptionAn update on the diagnosis and treatment options of Cushing’s disease. Description of the endoscopic endonasal approach for the management of CD. Surgical videos demonstration and comparison with the microscopic transsphenoidal approach. Surgical outcomes and adjuvant treatment.

Presenter Bio

Dr. Mary Koutourousiou is an attending Neurosurgeon and Assistant Professor at the University of Louisville. She is the Director of the Pituitary and Skull Base Program. Dr. Koutourousiou received her M.D. from the Aristotle University of Thessaloniki, Greece and completed her neurosurgical residency at the General Hospital of Athens “G. Gennimatas”, in Greece. She underwent subspecialty fellowship training in Endoscopic Pituitary Surgery and Minimally Invasive Neurosurgery at the UMC St. Radboud, Nijmegen, in the Netherlands. She moved to the United States in 2010 and completed four years of research and a clinical fellowship in Endoscopic and Open Skull Base Surgery at UPMC Presbyterian in Pittsburgh, Pennsylvania.

Dr. Koutourousiou has published extensively in the field of endoscopic skull base surgery. Her studies have been presented in national and international neurosurgical meetings. Dr. Koutourousiou’s work in skull base surgery has been recognized by the European Skull Base Society and the World Federation of Skull Base Societies.

Register here: https://attendee.gotowebinar.com/register/4982773766837282305?utm_source=newsletter_199&utm_medium=email&utm_campaign=webinar-announcement-endoscopic-endonasal-surgery-for-the-treatment-of-cushing-s-disease

Filed under: Cushing's, Meetings and Conferences, pituitary, Treatments, Webinar | Tagged: , , , , , | Leave a comment »

Webinar on Management Options for Pituitary Tumors March 22

Posted on March 19, 2016 by MaryO

Dr. Andaluz will cover the full breadth of treatment options from managing endocrine function, surgical procedures (transsphenoidal, endoscopic, and keyhole approaches), radiotherapy / radiosurgery, and the importance of getting care at a multidisciplinary center.

Dr. Norberto Andaluz is a neurosurgeon with the Mayfield Clinic and University of Cincinnati Brain Tumor Center. He is also Associate Professor of Neurosurgery at the University of Cincinnati, Surgical Director of the Neuroscience Intensive Care Unit, and Director of Neurotrauma at the University of Cincinnati Neuroscience Institute. He specializes in the treatment of all disorders and diseases of the brain and spine, but in particular, traumatic brain injury, aneurysms, arteriovenous malformations (AVMs), intracerebral hemorrhage, stroke, carotid artery disease, moyamoya disease and brain tumors (with special training in skull base tumors like pituitary adenoma). Dr. Andaluz received his medical degree from Unversidad Nacional de Rosario in Argentina. He completed his residency in neurosurgery at Instituto de Neurología y Neurocirugía at Sanatorio Parque in Rosario, Argentina and earned a fellowship in cerebrovascular surgery from the University of Cincinnati. Professional memberships include the American Heart Association, Congress of Neurological Surgeons, National Neurotrauma Society, Neurocritical Care Society and North American Skull Base Society.

Register at http://pituitary.org/events/webinar-management-options-for-pituitary-tumors

Filed under: Cushing's, Interview, Meetings and Conferences, pituitary, Webinar | Tagged: , , , , , , , , , , | Leave a comment »

RARE Webinar! Learning More on Informed Consent

Posted on November 5, 2015 by MaryO
a doctor in his office showing an informed consent document and pointing with a pen where the patient must to sign

a doctor in his office showing an informed consent document and pointing with a pen where the patient must to sign

 

Wednesday, November 18, 2015 10:00 am
Pacific Standard Time (San Francisco, GMT-08:00)

 

Informed consent is intended to provide patients, clinical trial participants, and others undergoing medical procedures with the information they need to make a decision about whether to undergo a specific procedure or participate in research. The process of informed consent can sometimes be very legal in nature leading to lack of clarity and misunderstanding. This webinar will explain the informed consent process, why patients should pay attention to it, and why rare disease advocates may want to get involved in the process.

Rare disease organizations play a critical role in connecting patients with researchers and the informed consent document is critically important. It outlines who will have access to research data that results from a study. Understanding the informed consent process and how to engage will help patients receive the greatest benefit.

 

Panelists:
Megan O'Boyle bio photoMegan O’Boyle

Megan’s 15-year-old daughter, Shannon has Phelan-McDermid Syndrome (PMS), an ultra rare condition. This diagnosis includes autism, intellectual disabilities, epilepsy, ADHD, lymphedema, and other medical conditions.

For the past 5 years Megan has volunteered for the PMS Foundation’s Research Support Committee. She is the Principal Investigator for the Phelan-McDermid Syndrome Data Network (PMS_DN, PCORnet) and the Phelan-McDermid Syndrome International Registry (PMSIR). She directed the biosample collection at the 2012 PMSF Family Conference, creating a biorepository of over 30 DNA and fibroblast samples.

Megan is passionate about the importance of the patient’s voice in: research, drug development, clinical trial design, development of related legislation, and quality of life decisions. She advocates for data sharing, collaborating with other advocacy groups, sharing resources, a genetics-first approach and streamlining IRB practices and policies.

Megan and her family live in Arlington, VA.

 

john-wilbanksJohn Wilbanks

John Wilbanks is the Chief Commons Officer at Sage Bionetworks. Previously, Wilbanks worked as a legislative aide to Congressman Fortney “Pete” Stark, served as the first assistant director at Harvard’s Berkman Center for Internet & Society, founded and led to acquisition the bioinformatics company Incellico, Inc., and was executive director of the Science Commons project at Creative Commons. In February 2013, in response to a We the People petition that was spearheaded by Wilbanks and signed by 65,000 people, the U.S. government announced a plan to open up taxpayer-funded research data and make it available for free. Wilbanks holds a B.A. in philosophy from Tulane University and also studied modern letters at the Sorbonne.

Moderator:
Danny_LevineDaniel Levine, Founder & Principal, Levine Media Group

Daniel Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. Since 2011, he has served as the lead editor and writer of Burrill Media’s acclaimed annual book on the biotech industry and hosts The Burrill Report’s weekly podcast. His work has appeared in The New York Times, The Industry Standard, TheStreet.com, and other national publications.

 

Register here: https://globalgenes.org/webinarinformedconsent/

Filed under: Clinical trials, Cushing's, Diagnostic Testing, Meetings and Conferences, Rare Diseases, Treatments, Webinar | Tagged: , , , , , | Leave a comment »

Webinar: Diagnosis and Management of Acromegaly: A Clinical Update

Posted on July 19, 2015 by MaryO

Presented by
Lisa Nachtigall, MD
Co-director Neuroendocrine Clinical Center
Massachusetts General Hospital

Register Here

After registering you will receive a confirmation email with details about joining the webinar.

Contact us at webinar@pituitary.org with any questions or suggestions.

Date: Monday, July 27, 2015
Time: 2:00 PM – 3:00 PM Pacific Daylight Time

Presenter Bio
Lisa B. Nachtigall, MD, is an Associate Professor of Medicine at Harvard Medical School, the clinical co-director of the Neuroendocrine Clinical Center at Massachusetts General Hospital and course director in Clinical Neuroendocrine at Harvard Medical School.

Dr. Nachtigall earned her medical degree from New York University (NYU) School of Medicine in New York City. She completed her internship and residency in internal medicine at Bellevue Hospital Center/NYU school of Medicine, and a clinical fellowship in endocrinology and metabolism, as well as a research fellowship in reproductive endocrinology at Massachusetts General Hospital/Harvard Medical School.

Dr. Nachtigall’s work has been published in the New England Journal of Medicine, the Journal of Clinical Endocrinology and Metabolism, Neurosurgery, Pituitary, and the Clinical Endocrinology among others. She serves on the editorial board of Pituitary and as an ad hoc reviewer for many endocrine journals. Dr Nachtigall has been a presenter at national and international medical conferences, and she is currently an investigator on several clinical studies of acromegaly and pituitary tumors.

Filed under: Meetings and Conferences, pituitary, Rare Diseases, Webinar | Tagged: , , , , | Leave a comment »

Next Page »